Skip to content

Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis

A Randomized,Controlled Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02303197
Enrollment
70
Registered
2014-11-27
Start date
2014-05-31
Completion date
2015-12-31
Last updated
2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

head and neck cancer, chemoradiotherapy, radioactive stomatitis

Brief summary

This study evaluates the efficiency and safety of ChiNing decoction to head and neck cancer patients with radioactive stomatitis. Half of participants will receive ChiNing decoction, while others will receive recombinant human epidermal growth factor (rhEGF) spray.

Detailed description

This study uses randomized, controlled clinical research methods, through the observation of the treatment group (ChiNing decoction orally) and control group (recombinant human epidermal growth factor rhEGF spray on oral mucosal surface ) at different time points before and after radiotherapy, to evaluate the radiotherapy of acute radiation oral mucosa reaction (RTOG grade), quality of life score (EORTCQLQ-H&N35 scale), oral pain (VAS score) and patient body weight changes of the two groups. At the same time,this study takes cast-off cells of oral mucosal to observe the microscopic characteristics of oral mucosa, and uses the ELISA method to detect IL-6 and TNF- alpha content in the saliva before and after radiotherapy.

Interventions

DRUGChiNing decoction

ChiNing decotion was reformed by Liangge San that was stemed from Prescriptions of the Bureau of Taiping People.

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Head and neck cancer patients with pathology and / or cytologic diagnosis; * Age 18\ 75 years old; * The expected life is more than 3 months; * The Karnofsky score (Karnofsky) ≥70 points; * The first course of radiotherapy in patients; * Patients had not received any anti tumour therapies for example of operation, radiotherapy,chemotherapy, biological treatment or isotope therapy system; * Patients volunteered to participate in this test and signed the informed consent, understand the purpose and test steps of the test, good compliance, comply with the relevant requirements of this test scheme; * No history of oral ulcer and salivary gland diseases

Exclusion criteria

* That do not meet the above the inclusion criteria; * Advanced critical cases, the expected survival is less than 3 months; * The patients had serious complications, such as cachexia, hepatic encephalopathy, gastrointestinal bleeding and coagulation functionobstruction, su ch as abnormal; * The submandibular gland pathological changes; * During radiotherapy taking other drugs in patients with treatment of stomatitis; * The patients with serious heart, brain, liver, kidney function

Design outcomes

Primary

MeasureTime frameDescription
Grading standard of RTOG in acute radiation injury of oral mucosal8 daysScore before the radiotherapy and every 1 week after the begining of the radiotherapy and after the end of radiotherapy

Secondary

MeasureTime frameDescription
The visual analogue scale of oral pain8 daysScore before the radiotherapy and every 1 week after the begining of the radiotherapy and after the end of radiotherapy
EORTCQLQ-H&N358 daysScore before the radiotherapy and every 1 week after the begining of the radiotherapy and after the end of radiotherapy
patient body weight changes8 daysScore before the radiotherapy and every 1 week after the begining of the radiotherapy and after the end of radiotherapy
Safety index2 daysChech the blood routine, urine routine, liver and kidney function, electrocardiogram before and after the radiotherapy

Other

MeasureTime frameDescription
IL-6 and TNF- alpha content2 daysWith distilled water repeatedly rinse of 1 min, 10 min after discarding the first mouthful of saliva, sit down, spit saliva to the sterile tube in 4 Centigrade, before and after the radiotherapy
takes cast-off cells of oral mucosal2 daysrinse the mouth with the physiological salt water , scrap sides of buccal oral mucosa 2 times appropriate efforts with appropriate effort, painted on a slide,before and after the radiotherapy

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026